• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脊髓灰质炎病毒2型Sabin疫苗株在灵长类动物中减毒的遗传基础。

Genetic basis of attenuation of the Sabin type 2 vaccine strain of poliovirus in primates.

作者信息

Macadam A J, Pollard S R, Ferguson G, Skuce R, Wood D, Almond J W, Minor P D

机构信息

National Institute for Biological Standards and Control, Potters Bar, Herts, United Kingdom.

出版信息

Virology. 1993 Jan;192(1):18-26. doi: 10.1006/viro.1993.1003.

DOI:10.1006/viro.1993.1003
PMID:8390752
Abstract

The type 2 live-attenuated vaccine strain of poliovirus (P2/Sabin) is associated with rare cases of poliomyelitis in vaccinees or their contacts. Recombinants were generated between infectious clones of a neurovirulent isolate from one such case (P2/117) and P2/Sabin and neurovirulence assays suggested that a maximum of six nucleotide differences between the two strains were responsible for their phenotypic difference. Site-directed mutagenesis of P2/Sabin showed that mutations at just two positions, at 481 in the 5' non-coding region and at VP1-143 in the capsid proteins, resulted in a highly neurovirulent virus. Other nucleotide changes may have weaker phenotypic effects. These results are consistent with those reported in the mouse model by Ren et al. [J. Virol. 65, 1377, (1991)] indicating that, for P2/Sabin at least, the same determinants of attenuation are important in both primates and transgenic mice expressing the poliovirus receptor. Sequence analysis of isolates from other vaccine-associated cases of poliomyelitis and from healthy vaccinees showed that both major determinants of attenuation are unstable on human passage, although selection pressures against an A at 481 are stronger than those against an Ile at 1143.

摘要

脊髓灰质炎病毒2型减毒活疫苗株(P2/萨宾株)与疫苗接种者或其接触者中罕见的脊髓灰质炎病例有关。从一例此类病例(P2/117)的神经毒力分离株的感染性克隆与P2/萨宾株之间产生了重组体,神经毒力测定表明,这两种毒株之间最多六个核苷酸差异导致了它们的表型差异。对P2/萨宾株进行定点诱变表明,仅5'非编码区481位和衣壳蛋白VP1-143位的两个位置发生突变,就会产生一种高度神经毒力的病毒。其他核苷酸变化可能具有较弱的表型效应。这些结果与Ren等人在小鼠模型中报道的结果一致[《病毒学杂志》65, 1377, (1991)],表明至少对于P2/萨宾株而言,在表达脊髓灰质炎病毒受体的灵长类动物和转基因小鼠中,相同的减毒决定因素都很重要。对其他疫苗相关脊髓灰质炎病例和健康疫苗接种者分离株的序列分析表明,尽管针对481位A的选择压力比对1143位异亮氨酸的选择压力更强,但两个主要减毒决定因素在人传代过程中都是不稳定的。

相似文献

1
Genetic basis of attenuation of the Sabin type 2 vaccine strain of poliovirus in primates.脊髓灰质炎病毒2型Sabin疫苗株在灵长类动物中减毒的遗传基础。
Virology. 1993 Jan;192(1):18-26. doi: 10.1006/viro.1993.1003.
2
Mutations in Sabin 2 strain of poliovirus and stability of attenuation phenotype.脊髓灰质炎病毒萨宾2型毒株的突变与减毒表型的稳定性
Virology. 1999 May 25;258(1):152-60. doi: 10.1006/viro.1999.9718.
3
Type 2 poliovirus recombinants isolated from vaccine-associated cases and from healthy contacts in Brazil.从巴西疫苗相关病例和健康接触者中分离出的2型脊髓灰质炎病毒重组体。
Acta Virol. 1996 Feb;40(1):27-33.
4
Genomic modifications in Sabin vaccine strains isolated from vaccination-associated cases, healthy contacts and healthy vaccinees.从疫苗接种相关病例、健康接触者和健康疫苗接种者中分离出的萨宾疫苗株的基因组修饰。
Acta Virol. 1996 Jun;40(3):157-70.
5
Prevalence of vaccine-derived polioviruses in stools of immunodeficient children in South Africa.南非免疫缺陷儿童粪便中疫苗衍生脊髓灰质炎病毒的流行情况。
J Appl Microbiol. 2006 Dec;101(6):1367-79. doi: 10.1111/j.1365-2672.2006.03020.x.
6
Identification of two determinants that attenuate vaccine-related type 2 poliovirus.两种减弱疫苗相关2型脊髓灰质炎病毒的决定因素的鉴定。
J Virol. 1991 Mar;65(3):1377-82. doi: 10.1128/JVI.65.3.1377-1382.1991.
7
Characterization of a rare natural intertypic type 2/type 3 penta-recombinant vaccine-derived poliovirus isolated from a child with acute flaccid paralysis.从急性弛缓性麻痹患儿中分离到的一株罕见的天然两型/三型重组疫苗衍生脊灰病毒的特性研究。
J Gen Virol. 2010 Feb;91(Pt 2):421-9. doi: 10.1099/vir.0.014258-0. Epub 2009 Oct 21.
8
A recombinant virus between the Sabin 1 and Sabin 3 vaccine strains of poliovirus as a possible candidate for a new type 3 poliovirus live vaccine strain.脊髓灰质炎病毒萨宾1型和萨宾3型疫苗株之间的重组病毒作为新型3型脊髓灰质炎病毒活疫苗株的潜在候选株。
J Virol. 1988 Aug;62(8):2828-35. doi: 10.1128/JVI.62.8.2828-2835.1988.
9
Development of candidates for new type 2 and type 3 oral poliovirus vaccines.新型2型和3型口服脊髓灰质炎疫苗候选产品的研发。
Dev Biol Stand. 1993;78:141-8.
10
Poliovirus attenuation and pathogenesis in a transgenic mouse model for poliomyelitis.脊髓灰质炎转基因小鼠模型中脊髓灰质炎病毒的减毒与发病机制
Dev Biol Stand. 1993;78:109-16.

引用本文的文献

1
Poliovirus shedding after sequential immunization of Sabin-strain inactivated polio vaccines and oral attenuated polio vaccines.在接种萨宾株灭活脊髓灰质炎疫苗和口服减毒脊髓灰质炎疫苗后脊髓灰质炎病毒的排出情况
NPJ Vaccines. 2025 Apr 23;10(1):81. doi: 10.1038/s41541-025-01134-9.
2
Immunodeficiency-Related Vaccine-Derived Poliovirus (iVDPV) Infections: A Review of Epidemiology and Progress in Detection and Management.免疫缺陷相关疫苗衍生脊髓灰质炎病毒(iVDPV)感染:流行病学及检测与管理进展综述
Pathogens. 2024 Dec 20;13(12):1128. doi: 10.3390/pathogens13121128.
3
Opening a 60-year time capsule: sequences of historical poliovirus cold variants shed a new light on a contemporary strain.
开启一个60年的时间胶囊:历史脊髓灰质炎病毒冷变体序列为一种当代毒株带来新线索。
Virus Evol. 2024 Jul 29;10(1):veae063. doi: 10.1093/ve/veae063. eCollection 2024.
4
CNS Viral Infections-What to Consider for Improving Drug Treatment: A Plea for Using Mathematical Modeling Approaches.中枢神经系统病毒感染——改善药物治疗需要考虑的因素:呼吁采用数学建模方法。
CNS Drugs. 2024 May;38(5):349-373. doi: 10.1007/s40263-024-01082-3. Epub 2024 Apr 5.
5
Improvement of the qmosRT-PCR Assay and Its Application for the Detection and Quantitation of the Three Serotypes of the Novel Oral Polio Vaccine in Stool Samples.qmosRT-PCR检测方法的改进及其在粪便样本中新型口服脊髓灰质炎疫苗三种血清型检测和定量分析中的应用
Vaccines (Basel). 2023 Nov 19;11(11):1729. doi: 10.3390/vaccines11111729.
6
Genetic stabilization of attenuated oral vaccines against poliovirus types 1 and 3.遗传稳定减毒口服疫苗对脊髓灰质炎病毒 1 型和 3 型的作用。
Nature. 2023 Jul;619(7968):135-142. doi: 10.1038/s41586-023-06212-3. Epub 2023 Jun 14.
7
Quantitative RT-PCR Assays for Quantification of Undesirable Mutants in the Novel Type 2 Oral Poliovirus Vaccine.用于定量新型2型口服脊髓灰质炎病毒疫苗中不良突变体的定量逆转录聚合酶链反应检测法
Vaccines (Basel). 2022 Aug 25;10(9):1394. doi: 10.3390/vaccines10091394.
8
Virulence of Enterovirus A71 Fluctuates Depending on the Phylogenetic Clade Formed in the Epidemic Year and Epidemic Region.肠道病毒 A71 的毒力随流行年份和流行地区形成的进化枝而波动。
J Virol. 2021 Nov 9;95(23):e0151521. doi: 10.1128/JVI.01515-21. Epub 2021 Sep 15.
9
Evaluation and validation of next-generation sequencing to support lot release for a novel type 2 oral poliovirus vaccine.新一代测序技术用于支持新型2型口服脊髓灰质炎疫苗批放行的评估与验证
Vaccine X. 2021 Jun 11;8:100102. doi: 10.1016/j.jvacx.2021.100102. eCollection 2021 Aug.
10
The Early Evolution of Oral Poliovirus Vaccine Is Shaped by Strong Positive Selection and Tight Transmission Bottlenecks.口服脊髓灰质炎疫苗的早期进化受到强烈的正选择和严格的传播瓶颈的影响。
Cell Host Microbe. 2021 Jan 13;29(1):32-43.e4. doi: 10.1016/j.chom.2020.10.011. Epub 2020 Nov 18.